Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 73.5 CHF -2%
Market Cap: CHf1B

Medartis Holding AG
Net Change in Cash

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Medartis Holding AG
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Medartis Holding AG
SIX:MED
Net Change in Cash
-CHf105.7m
CAGR 3-Years
-19%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Alcon AG
SIX:ALC
Net Change in Cash
-$149m
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Net Change in Cash
-CHf1.2m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Net Change in Cash
-CHf16m
CAGR 3-Years
-15%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
IVF Hartmann Holding AG
SIX:VBSN
Net Change in Cash
-CHf3.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medartis Holding AG
Glance View

Market Cap
1B CHF
Industry
Health Care

Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

MED Intrinsic Value
72.44 CHF
Overvaluation 1%
Intrinsic Value
Price CHf73.5

See Also

What is Medartis Holding AG's Net Change in Cash?
Net Change in Cash
-105.7m CHF

Based on the financial report for Dec 31, 2025, Medartis Holding AG's Net Change in Cash amounts to -105.7m CHF.

What is Medartis Holding AG's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-44%

The average annual Net Change in Cash growth rates for Medartis Holding AG have been -19% over the past three years , -44% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett